Novavax Stock Soars on a $1.6 Billion U.S. Infusion for #Covid19Vaccine  $NVAX $ATOS $JNJ announcing that the U.S. government had awarded it $1.6 billion to test and manufacture its Covid-19 vaccine. The company will deliver 100 mi…https://t.co/QI2hYX5jgK https://t.co/TCYcTuHjaa